Paper17575261
VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice.
Messina S and 11 others. FASEB J, 2007. Cited by 88 papers, by iCite.
Cite this record
ConductScience Library. VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice. Papers, record 17575261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17575261
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dependovirus | Major topic |
| Gene Transfer Techniques | Major topic |
| Muscle, Skeletal | Major topic |
| Muscular Dystrophies | Major topic |
| Regeneration | Major topic |
| Vascular Endothelial Growth Factor A | Major topic |
| Animals | |
| Mice |
Source PubMed
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42930835 | An Ion-Releasing Bioactive Glass Accelerates Skeletal Muscle Regeneration and Functional Recovery Following Acute Injury. | J Funct Biomater | 2026 | https://conductscience.org/library/papers/42930835 | PubMed |
| 42311330 | Skeletal muscle overuse injury: pathophysiological mechanisms, molecular pathways, and rehabilitation strategies. | Front Physiol | 2026 | https://conductscience.org/library/papers/42311330 | PubMed |
| 41893211 | A Borophosphate Glass Doped with Cobalt Oxide Improves Skeletal Muscle Structure and Function in Myopathic Mice. | J Funct Biomater | 2026 | https://conductscience.org/library/papers/41893211 | PubMed |
| 41630990 | Improving angiogenesis ameliorates the efficacy of ASO-based exon skipping for the treatment of Duchenne muscular dystrophy. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/41630990 | PubMed |
| 41328300 | Genetic strategies for therapy of Duchenne muscular dystrophy. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/41328300 | PubMed |
| 41238663 | Circulating protein biomarkers identified in two independent clinical trial cohorts of glucocorticoid-naive Duchenne muscular dystrophy patients. | Sci Rep | 2025 | https://conductscience.org/library/papers/41238663 | PubMed |
| 41096544 | Hypoxia and Tissue Regeneration: Adaptive Mechanisms and Therapeutic Opportunities. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096544 | PubMed |
| 39519374 | Angiopoietin 1 Attenuates Dysregulated Angiogenesis in the Gastrocnemius of DMD Mice. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39519374 | PubMed |
| 38842166 | Endothelial cell signature in muscle stem cells validated by VEGFA-FLT1-AKT1 axis promoting survival of muscle stem cell. | Elife | 2024 | https://conductscience.org/library/papers/38842166 | PubMed |
| 37626761 | Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice. | Biomedicines | 2023 | https://conductscience.org/library/papers/37626761 | PubMed |
| 37524876 | Inhibiting the cytosolic function of CXXC5 accelerates diabetic wound healing by enhancing angiogenesis and skin repair. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/37524876 | PubMed |
| 37445602 | Microvascular Skeletal-Muscle Crosstalk in Health and Disease. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37445602 | PubMed |
| 36873982 | Vascular therapy for Duchenne muscular dystrophy (DMD). | Fac Rev | 2023 | https://conductscience.org/library/papers/36873982 | PubMed |
| 35892681 | VEGF-A and FGF4 Engineered C2C12 Myoblasts and Angiogenesis in the Chick Chorioallantoic Membrane. | Biomedicines | 2022 | https://conductscience.org/library/papers/35892681 | PubMed |
| 35328504 | Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1). | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35328504 | PubMed |
| 34031263 | MicroRNA-126 engineered muscle-derived stem cells attenuates cavernosa injury-induced erectile dysfunction in rats. | Aging (Albany NY) | 2021 | https://conductscience.org/library/papers/34031263 | PubMed |
| 33925757 | Age-Dependent Dysregulation of Muscle Vasculature and Blood Flow Recovery after Hindlimb Ischemia in the mdx Model of Duchenne Muscular Dystrophy. | Biomedicines | 2021 | https://conductscience.org/library/papers/33925757 | PubMed |
| 33898634 | VEGFR-1/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy. | Mol Ther Methods Clin Dev | 2021 | https://conductscience.org/library/papers/33898634 | PubMed |
| 33164678 | Targeting IRES-dependent translation as a novel approach for treating Duchenne muscular dystrophy. | RNA Biol | 2021 | https://conductscience.org/library/papers/33164678 | PubMed |
| 32691346 | Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future. | Pharmacol Rep | 2020 | https://conductscience.org/library/papers/32691346 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17575261
GET https://conductscience.org/api/papers/v1/17575261/cited_by?page=2